Outcome of Board Meeting
AMRUTANJAN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Amrutanjan Health Care reported audited FY2026 results with revenue from operations of Rs 50,255.27 lakhs, up 11.2% from Rs 45,181.63 lakhs in FY2025. Profit after tax grew 13.9% to Rs 5,791.78 lakhs from Rs 5,083.47 lakhs, with EPS at Rs 20.03 (vs Rs 17.58). The Board recommended a final dividend of Rs 2.90 per share. Two exceptional items totaling Rs 885.67 lakhs were recorded: Rs 760.50 lakhs for retrospective lease rent revision (one-time impact for Tamil Nadu land lease) and Rs 125.17 lakhs due to new labour codes. The auditors (BSR & Co. LLP) issued an unmodified opinion. The Board also appointed Mr. Ramaswami Krishnan as Additional Independent Director, re-appointed Mr. Muralidharan Swayambunathan for a second term, approved a revised ESOP 2 scheme, and appointed PKF Sridhar & Santhanam as internal auditors.
Strong bottom-line growth with PAT up ~14% and positive cash generation of Rs 3,596.77 lakhs from operations. Exceptional items are non-recurring and do not affect core operations. Dividend and director appointments are positive governance signals for shareholders.